“…For many years, there has been an increasing demand in developing efficient production processes for biopharmaceuticals like monoclonal antibodies (Chotteau et al, 2007;Kunert et al, 2000), recombinant proteins (Baker et al, 2001;Gaillet et al, 2007), and viral vaccines (Genzel et al, 2004;Lohr et al, 2009) using animal and human cell lines as cell substrate. However, a major problem that can be seen with almost all the producer cell lines is the highly inefficient use of nutrients.…”